Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-14, with 7 holding rows worth $4,024,354.

Accession
0000919574-26-003017
Filed
2026-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 7 entries on the cover page, a total value of $4,024,354 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,024,354 with VALUE read as dollars as filed, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPDR GOLD TR78463V107GOLD SHS7,623$3,279,923dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
Berkshire Hathaway Inc084670702COM727$348,341dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
KYVERNA THERAPEUTICS INC501976104COMMON STOCK18,773$162,012dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
LEXEO THERAPEUTICS INC52886X107COMMON STOCK13,943$80,032dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
X4 PHARMACEUTICALS INC98420X202COMMON STOCK15,557$64,249dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
INHIBIKASE THERAPEUTICS INC45719W205COMMON STOCK28,453$47,801dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK20,946$41,996dollars as filedThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-26-003017this filing2026-05-14acceptance time not in the bulk data set